21.12.09 18:40 Age: 81 days
Institut Paoli Calmettes and IPSOGEN presented a new study supporting the pivotal role of tumor grade in chemotherapy prescription at the 32nd Annual San Antonio Breast Cancer Symposium
Category: Breast Cancer
The study reinforces tumor grade as the most contributive factor for adjuvant chemotherapy in N-/M- IBC, together with tumor size
Marseille, France, Dec 21, 2009 – Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS), December 9-13, 2009.
More
